These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18696377)

  • 1. Not all injection drug users are created equal: heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia.
    Kuniholm MH; Aladashvili M; Del Rio C; Stvilia K; Gabelia N; Chitale RA; Tsertsvadze T; Nelson KE
    Subst Use Misuse; 2008; 43(10):1424-37. PubMed ID: 18696377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.
    Shapatava E; Nelson KE; Tsertsvadze T; del Rio C
    Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S35-8. PubMed ID: 16769443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
    Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
    Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
    Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
    Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
    Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
    Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to hepatitis B virus and hepatitis C virus in residential detoxification clients in Jamaica.
    Smikle MF; Dowe G; Williams EM; Thesiger C
    Hum Antibodies; 2000; 9(4):231-3. PubMed ID: 11341177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study.
    Quan VM; Go VF; Nam le V; Bergenstrom A; Thuoc NP; Zenilman J; Latkin C; Celentano DD
    AIDS Care; 2009 Jan; 21(1):7-16. PubMed ID: 19085215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: a population-based survey of the adult population of T'bilisi, Republic of Georgia.
    Stvilia K; Tsertsvadze T; Sharvadze L; Aladashvili M; del Rio C; Kuniholm MH; Nelson KE
    J Urban Health; 2006 Mar; 83(2):289-98. PubMed ID: 16736377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS; Singh NB; Singh HL; Singh YM
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
    Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
    Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection with human immunodeficiency virus and hepatitis viruses in Chinese drug addicts.
    Baozhang T; Kaining Z; Jinxing K; Ruchang X; Ming L; Caixia Z; Li T
    Epidemiol Infect; 1997 Dec; 119(3):343-7. PubMed ID: 9440438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
    Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis B, hepatitis C, syphilis and HIV in Georgian blood donors.
    Butsashvili M; Tsertsvadze T; McNutt LA; Kamkamidze G; Gvetadze R; Badridze N
    Eur J Epidemiol; 2001; 17(7):693-5. PubMed ID: 12086085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China-Myanmar border city: results from a Respondent-Driven Sampling Survey in 2012.
    Li L; Assanangkornchai S; Duo L; McNeil E; Li J
    PLoS One; 2014; 9(9):e106899. PubMed ID: 25203256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual behaviors and seroprevalence of HIV, HBV, and HCV among hill tribe youths of Northern Thailand.
    Apidechkul T
    BMC Public Health; 2019 Aug; 19(1):1101. PubMed ID: 31412838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.